Abstract Submission
For Oral and Poster Presentations:
Submission Period
Abstract Submission Deadline: November 30 (Mon), 2026 (12:00pm Noon, JST)
Abstract Correction Deadline: December 7 (Mon), 2026 (12:00pm Noon, JST)
Flash Talk PDF Submission Deadline: February 12 (Fri.), 2027
Participants who have registered for the "Poster & Flash Talk" presentation type will receive separate instructions regarding Flash Talk PDF submission and e-poster upload in due course.
Language
English
Presentation Format
Oral Presentation or Poster Presentation with Flash Talk.
Categories
Please choose the appropriate category and subcategory from the list below.
Category
Research and Development I (Translation and Implementation Stage): Projects that have been transferred to national projects such as Wakumoda* or a company, or are expected to be transferred within roughly two years.
Research and Development II (Product Development Stage): Projects expected to be transferred to national projects such as Wakumoda or a company within roughly five years.
Research and Development III (Seed Creation Stage): Research aimed at generating novel technologies, modalities, or candidate products for the prevention, diagnosis, or treatment of infectious diseases (e.g., vaccine candidates, antibodies, diagnostic technologies, adjuvants, drug targets). [Research focused on creating new solutions]
Research and Development IV (Basic and Exploratory Research Stage): Research aimed at generating new knowledge and elucidating mechanisms related to infectious diseases, thereby deepening our understanding of pathogens, host responses, disease emergence and transmission, and their societal impacts (e.g., virology, vaccine science, immunology, pathogenesis, social sciences). [Research focused on advancing fundamental understanding]
Expanding from Vaccines to Medical Countermeasures (MCMs) : Center Directors and Support Institutional Heads who will give an oral presentation in the session "Expanding from Vaccines to Medical Countermeasures (MCMs)" are requested to select this category.
Subcategory
| A | Immunology | K | Laboratory Animal Science |
| B | Vaccine Science | L | Chemistry |
| C | Virology | M | Engineering |
| D | Bacteriology | N | Informatics |
| E | Parasitology | O | Social Sciences |
| F | Infectious Disease Medicine | P | Drug Discovery |
| G | Clinical Research | Q | Diagnostics |
| H | Genetics/Genome Science | R | Drug Discovery & Diagnostics Support Core Technologies |
| I | Molecular Biology/Biochemistry/Cell Biology | S | Others |
| J | Structural Biology |
Presentation Type
| Oral (Expanding from Vaccines to Medical Countermeasures (MCMs)) | |
| Oral (Next Generation Researchers) | |
| Oral (Vaccine Session) | |
| Oral (AI Session) | |
| Oral (Therapeutics Session) | |
| Oral (Diagnostics Session) | |
| Poster & Flash Talk (On-site) | |
| Poster & Flash Talk (On-site) - Seeking Collaborators | |
| Poster board for Support Institutions Area (On-site) | |
| Poster board ＆ Table for Support Institutions Booth (On-site) | |
| Corporate Exhibitions(Poster Board and Table) | |
| Corporate Exhibitions(Poster Board) | |
| Seminar on Collaboration between Industry, Academia, and Government | |
| Invited seminar | |
| GMP Seminar |
• Oral Presentation (Next Generation Researchers): In addition to presenting your research, please be sure to include your "future research vision", including the goals and impact you hope to achieve through your research.
• Poster presenters are also requested to give a Flash Talk (on-site).
• Poster & Flash Talk (on-site) - Seeking Collaborators: Posters submitted by participants who wish to recruit collaborators with expertise or technologies needed for their research, or who would like to showcase their own expertise and technologies to initiate new collaborative research opportunities, will be designated and displayed as collaboration-seeking posters.
• Note on Poster ＆ Flash Talk: If the number of applications exceeds the available poster presentation space and/or Flash Talk time slots, some presentations may be accepted as e-posters only.
How to Submit
Please submit abstracts using the submission form by clicking the button below.
- You can enter up to 30 institutions and 35 authors.
- Title length: Maximum of 200 characters.
- Abstract length: Maximum of 2,000 characters.
Modifying or Withdrawing an Abstract
You can review, modify, or withdraw your submitted abstract until the submission deadline.
To do so, log in to the abstract submission system using the login ID and password obtained during registration.
You cannot make any changes after the abstract submission deadline.
Important Notes
Please refer to the login page for recommended browsers for the abstract submission system. Even when accessing from a recommended environment, you may encounter difficulties due to your computer settings. If this occurs, please try submitting your abstract from a different computer.
The submission system may become very congested just before the deadline, so we recommend submitting early. The symposium secretariat is not responsible for any submission issues resulting from network congestion.
The secretariat is not responsible for any errors made by the submitter. Please check your submission carefully before clicking the submit button.
Inquiries
SECRETARIAT
c/o The University of Tokyo
Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA)
3-15-5-201 Shirokanedai, Minato-ku, Tokyo 108-0071, Japan
Contact